TCF7L1
Transcription factor 7-like 1
Also known as: TCF3, TF7L1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HCS4
- Gene
- TCF7L1
- Ensembl
- ENSG00000152284
- Chromosome
- 2
- Canonical length
- 588 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a member of the T cell factor/lymphoid enhancer factor family of transcription factors. These transcription factors are activated by beta catenin, mediate the Wnt signaling pathway and are antagonized by the transforming growth factor beta signaling pathway. The encoded protein contains a high mobility group-box DNA binding domain and participates in the regulation of cell cycle genes and cellular senescence. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
588 residues, UniProt reviewed canonical sequence.
>Q9HCS4|TCF7L1
1 MPQLGGGGGG GGGGSGGGGG SSAGAAGGGD DLGANDELIP FQDEGGEEQE PSSDSASAQR
61 DLDEVKSSLV NESENQSSSS DSEAERRPQP VRDTFQKPRD YFAEVRRPQD SAFFKGPPYP
121 GYPFLMIPDL SSPYLSNGPL SPGGARTYLQ MKWPLLDVPS SATVKDTRSP SPAHLSNKVP
181 VVQHPHHMHP LTPLITYSND HFSPGSPPTH LSPEIDPKTG IPRPPHPSEL SPYYPLSPGA
241 VGQIPHPLGW LVPQQGQPMY SLPPGGFRHP YPALAMNASM SSLVSSRFSP HMVAPAHPGL
301 PTSGIPHPAI VSPIVKQEPA PPSLSPAVSV KSPVTVKKEE EKKPHVKKPL NAFMLYMKEM
361 RAKVVAECTL KESAAINQIL GRKWHNLSRE EQAKYYELAR KERQLHSQLY PTWSARDNYG
421 KKKKRKREKQ LSQTQSQQQV QEAEGALASK SKKPCVQYLP PEKPCDSPAS SHGSMLDSPA
481 TPSAALASPA APAATHSEQA QPLSLTTKPE TRAQLALHSA AFLSAKAAAS SSGQMGSQPP
541 LLSRPLPLGS MPTALLASPP SFPATLHAHQ ALPVLQAQPL SLVTKSAHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCF7L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 40 nTPM
- adipose tissue: 36 nTPM
- breast: 32 nTPM
- cervix: 29 nTPM
- thyroid gland: 29 nTPM
- colon: 26 nTPM
Single-cell type
- podocytes: 594 nCPM
- renal collecting duct principal cells: 433 nCPM
- alveolar cells type 2: 430 nCPM
- fibro-adipogenic progenitors: 363 nCPM
- pituitary stem cells: 296 nCPM
- bergmann glia: 252 nCPM
Immune cell
- basophil: 5 nTPM
- naive B-cell: 1.3 nTPM
- neutrophil: 1.2 nTPM
- eosinophil: 1 nTPM
- memory B-cell: 1 nTPM
- naive CD8 T-cell: 0.8 nTPM
Brain region
- midbrain: 37 nTPM
- choroid plexus: 37 nTPM
- medulla oblongata: 32 nTPM
- thalamus: 30 nTPM
- basal ganglia: 30 nTPM
- hypothalamus: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.36
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- canonical Wnt signaling pathway
- chromatin organization
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- regulation of Wnt signaling pathway
Molecular functions
- DNA binding
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TCF7L1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCF7L1 as an antibody target. Whether an autoantibody or antibody against TCF7L1 could matter depends on whether native TCF7L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCF7L1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TCF7L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...